SS-31 50mg User Guide

This guide is for SS-31 50mg. It covers reconstitution, conservative dose math, subQ injection basics, side effects, and storage.

You can find this product here: SS-31.

---

ABOUT THIS PEPTIDE

SS-31, also called elamipretide, is a mitochondria-targeted peptide. It is studied for the way it binds to cardiolipin, a fat that helps the inner mitochondrial membrane work properly. The basic goal is steadier energy production and less oxidative stress inside cells.

People usually look into SS-31 for energy, endurance, fatigue resistance, recovery, or broader mitochondrial support. Reports tend to be subtle. Some people notice better training tolerance or steadier energy, while others do not feel a clear change.

An FDA-approved elamipretide drug called Forzinity now exists for Barth syndrome. Its approved dose is 40mg daily for patients who meet specific criteria. That prescription product is not interchangeable with this vial, and its disease-specific dose should not be copied into a general wellness routine.

Compared with MOTS-c, SS-31 is the more direct mitochondrial-membrane peptide. MOTS-c is usually discussed around metabolic signaling and glucose use. SS-31 is discussed around membrane stability, electron transport, and ATP production.

Quick notes:

• Best known for: mitochondrial function, energy, endurance, and fatigue research.
• Evidence level: a prescription form exists for one rare disease, but general wellness use has not been established.
• Community theme: subtle energy or recovery support, or no obvious effect.
• Main watch-out: treating the approved 40mg drug dose as a general-purpose protocol.

---

SUPPLIES YOU’LL NEED

• Insulin needles, https://www.amazon.com/dp/B07P2KK5P7
• Alcohol swabs, https://www.amazon.com/dp/B07F2MQ9NJ
• Reconstitution solution (bacteriostatic water), https://progressionpeptides.com/product/bacteriostatic-water/

---

RECONSTITUTION (MIXING)

Each vial contains 50mg of SS-31. Add 3mL of bacteriostatic water.

1. Draw up 300 units of bacteriostatic water in total.
2. Add it slowly down the inside wall of the vial.
3. Swirl gently until dissolved. Do not shake.

With this mix, 1 unit = about 0.167mg of SS-31.

Units on syringe	Approx dose
3 units	0.5mg
6 units	1mg
12 units	2mg
18 units	3mg
30 units	5mg

This vial is more concentrated than the 10mg version. Double-check the units before every dose.

---

DOSING SCHEDULE

Community protocols are much lower than the disease-specific prescription dose. A cautious first dose is 3 units (about 0.5mg). If tolerated, many community routines use 6-12 units (1-2mg) once daily or several times per week.

Simple starting protocol

• First 3-4 doses: 3 units (about 0.5mg).
• If tolerated: 6 units (1mg).
• Use in the morning or before training.
• Run a focused 4-8 week block, then stop and reassess.

Do not jump to the prescription 40mg dose. That amount comes from a specific drug product and a rare-disease treatment plan.

---

HOW TO INJECT

Watch this quick video for the basic subQ process: https://www.youtube.com/watch?v=e9NGueNM03I

1. Wipe the vial top with an alcohol swab.
2. Draw the dose and check the syringe units again.
3. Pinch a small area of belly or thigh fat and inject slowly.
4. Rotate injection sites.

---

SIDE EFFECTS AND CAUTIONS

Possible effects include injection-site redness or itching, headache, nausea, fatigue, dizziness, flushing, or sleep changes. Prescription elamipretide commonly causes injection-site reactions.

Use medical guidance with heart, kidney, liver, or neurological disease, pregnancy or breastfeeding, or a medication-heavy routine. Stop and get help for trouble breathing, facial swelling, fainting, chest pain, or a severe reaction.

---

STORAGE

Keep the mixed vial refrigerated, cold, dry, and dark. Avoid repeated warm-ups and unnecessary punctures. Discard it if the liquid becomes cloudy, changes color, develops particles, or looks contaminated.

Write the mixing date on the vial. Aim to use it within 4 weeks and do not stretch it past 6 weeks.

---

RESEARCH NOTES

• https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215244s000lbl.pdf
• https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=146bf34c-76f2-48db-ac07-fb29cce2cd75
• https://swolverine.com/blogs/blog/ss-31-peptide-mitochondrial-protection-and-performance-potential